| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Repayment of 2024 notes | 0 | - |
| Net proceeds from issuance of 2030 notes | 0 | - |
| Net cash provided by (used in) financing activities | -948,820 | -937,991 |
| Effect of exchange rates on cash and cash equivalents | 6,522 | 6,319 |
| Net increase (decrease) in cash and cash equivalents | -1,086,794 | -1,222,984 |
| Cash and cash equivalents at beginning of period | 2,412,864 | - |
| Cash and cash equivalents at end of period | 1,326,070 | - |
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)